Strong patent protection is essential for a start-up biotechnology company and can be a valuable company asset. However, it is also expensive, with costs ranging from tens to hundreds of thousands of dollars over time. This session will focus on how to get the most out of your patent dollars.
SPEAKERS
Linda Kurdyduk - Waratah Pharmaceuticals Inc., Transition Therapeutics Inc.
Andre Uddin, VP Strategic Development, Transition Therapeutics Inc.
Konrad Powell-Jones, Marketing and licensing, U of T and Mount Sinai
Tom Corr, Commericialization, IT Group, U of T
Anita Nador, McCarthy Tetrault
TOPICS ADDRESSED
Develop an IP strategy that protects your company's assets
Identify the technology that needs protection- software, products, methods, etc.
Select appropriate protection means – patents, copyright, or trade secrets
Determine where and when to file
Coordinate IP protection with your development activities
Address ownership and inventorship issues – employment, service and collaboration agreements, and IP policies
Manage costs of obtaining patent protection
Understand how investors evaluate intellectual property
Discuss strategic out-licensing of your IP
DATE | TIME | LOCATION
December 4, 2006 - December 4, 2006 6:00PM - 9:00PM MaRS Centre
101 College St, Toronto
Who's Your City? Author: Richard Florida Publisher: Basic Books (US), Random House Canada (Mar 11 2008) Globalization does not make the world flat. Richard Florida believes place matters when it comes to innovation: ...